SCHEMBL2012500

SCHEMBL2012500

NCCc1cc(Cl)c2cccnc2c1N1CCN(C(=O)c2cccc(F)c2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.52
SMN1; SMN2 Q16637 6/20 0.48
HTT P42858 2/20 0.48
ALDH1A1 P00352 6/20 0.45
GAA P10253 2/20 0.45
ATM Q13315 1/20 0.45
CYP3A4 P08684 5/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C9 P11712 3/20 0.45
CYP1A2 P05177 2/20 0.45
CYP2C19 P33261 2/20 0.45
TSHR P16473 4/20 0.44
HSD17B10 Q99714 4/20 0.44
HPGD P15428 3/20 0.44
KDM4E B2RXH2 2/20 0.43
KMT2A Q03164 2/20 0.43
LMNA P02545 1/20 0.43
HSP90AA1 P07900 1/20 0.43
RAB9A P51151 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2011832 0.91 L3MBTL1 (0.50) MAPTSMN1; SMN2HTTALDH1A1TSHR
SCHEMBL2012009 0.90 MAPT (0.46) MAPTSMN1; SMN2HTTALDH1A1TSHR
SCHEMBL2015402 0.88 AKR1C3 (0.43) MAPTSMN1; SMN2HTTALDH1A1KDM4E
SCHEMBL2013896 0.88 MAPT (0.52) MAPTSMN1; SMN2HTTALDH1A1GAA
SCHEMBL2017795 0.87 MEN1 (0.52) MAPTSMN1; SMN2HTTALDH1A1CYP3A4
SCHEMBL2016546 0.85 KDM4E (0.53) MAPTSMN1; SMN2HTTALDH1A1HSD17B10
SCHEMBL2014194 0.83 L3MBTL1 (0.48) MAPTSMN1; SMN2HTTALDH1A1GAA
SCHEMBL2163234 0.83 MAPT (0.54) MAPTSMN1; SMN2HTTALDH1A1GAA
SCHEMBL2017422 0.82 MAPT (0.43) MAPTSMN1; SMN2HTTALDH1A1GAA
SCHEMBL2163396 0.82 MAPT (0.54) MAPTSMN1; SMN2HTTALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011075630-A1 SUBSTITUTED FUSED ARYL AND HETEROARYL DERIVATIVES AS PI3K INHIBITORS INCYTE CORPORATION (US) 2011-06-23 WO disclosed